|
2008 |
Nov | Dec |
2009 |
Jan | Feb | Mar |
November 2008
International Symposium on the Biosafety of Genetically Modified Organisms (ISBGMO)
Host: International Society for Biosafety Research
Date: Sunday, November 16, 2008 - Friday, November 21, 2008
Location: Te Papa, Wellington, New Zealand
Contact: The Conference Company
Phone: +64 9 360 1240
Fax: +64 9 360 1242
Email: isbgmo@tcc.co.nz
Website: www.isbgmo.info
Description: Held biennially by the International Society for Biosafety Research, the 10th ISBGMO will be the first in the Southern Hemisphere and will hightlight past achievements and future directions in evironmental biosafety research and risk assessment of GMOs.
Other: Registration: http://www.isbgmo.info/registration/
Publications: http://www.isbgmo.info/programme/
Validation of Analytical Methods Course
Host: IBC Professional Training Academy
Date: Thursday, November 20, 2008 - Friday, November 21, 2008
Location: Chicago, IL
Contact: IBC Customer Service
Phone: (800) 390-4078
Fax: (941) 365-0104
Email: reg@ibcusa.com
Website: www.ibclifesciences.com/C5166
Description: This course provides the attendee with a comprehensive discussion of the principles and procedures that are part of a modern analytical quality control strategy for biologicals. This includes the purpose of the method, key parameters to consider for optimization and robustness as well as detailed descriptions of the validation activities (including cGMP documentation needs, such as pre-approved protocols and reports).
EuroPLX 38 Barcelona (Spain)
Host: RauCon business development
Date: Monday, November 24, 2008 - Tuesday, November 25, 2008
Time: 9 a.m. - 6 p.m; 8:30 a.m. - 4:30 p.m.
Location: Hilton Diagonal Mar Barcelona, Passeig del Taulat 262-264, 08019 Barcelona, Spain. Phone +34 93 507 0707, fax +34 93 507 0700
Contact: Mrs. Anke Rau
Phone: +49 6222 9807-22
Toll Free Phone: -
Fax: +49 6222 9807-77
Email: meetyou@europlx.com
Website: http://www.europlx.com
Description: Partnering event for Pharma and Biopharma Business Development & Licensing Executives seeking to partner in prescription drugs ranging from clinical candidates to value added generics, including bio-generics and biosimilars. More than 20 pre-scheduled appointments per company from 30 countries worldwide.
Other: EuroPLX Meetings are regular European events since 1995, where business development managers convene to negotiate deals in a highly organised process.
CHI'S BRIDGING THE BUSINESS DEVELOPMENT ALLIANCE MANAGEMENT INTERFACE
Host: Cambridge Healthtech Institute
Date: Sunday, November 30, 2008 - Tuesday, December 04, 2008
Time: All Day Event
Location: Boston, MA
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com/abd/overview.aspx?c=675
Description: The model for new pharmaceutical product development is changing rapidly and your company's strategy must respond, whether you are a large pharmaceutical company, or an emerging biotech company. Alternative sourcing programs are emerging. Alliances are becoming more and more central to new product development as alliance centric external development programs emerge. Movements towards better integration of business development and alliance management functions and integration of alliances and acquisition, are also transforming how companies are finding, evaluating, structuring and negotiating deals and working with their external partners to develop new products and commercialize those products. Immediately followed by The ASAP-CHI Bio-Pharm Alliance Summit, be part of these premier events!
www.healthtech.com
December 2008
26th Army Science Conference
Host: OASA(ALT)
Date: Monday, December 01, 2008 - Thursday, December 04, 2008
Location: JW Marriott Orlando Grande Lakes, Orlando, Florida
Contact:
Phone:
Fax: 757-357-5108
Email: www.technical.conferences@charterinternet.com
Website: www.asc2008.com
Description: The 26th Army Science Conference is a biennial event sponsored by the Assistant Secretary of the Army for Acquisition, Logistics and Technology. The conference goal is to promote and strategically communicate the Army vision for Transformation of the Current and Future Force through S&T. The conference will support the Army in strategically communicating that it is a high-tech force. Biotechnology is one of seven primary areas being focused upon at the conference.
BIT's 1st Annual World Vaccine Congress 2008
Host: BIT Life Sciences, Inc.
Date: Monday, December 01, 2008 - Friday, December 05, 2008
Time: 08:30-17:30
Location: Baiyun International Convention Center, Guangzhou, China
Contact: Annie Sun
Phone: 01186-411-84799609
Fax: 01186-411-84799629
Email: annie@vaccinecon.com
Website: http://www.bitlifesciences.com/wcv2008
Description: BIT Life Sciences'1st Annual World Vaccine Congress 2008, with a theme of "Building an Olympian Meeting Platform for Vaccine World, which will be held during December 1-5, 2008 at Baiyun International Convention Center, Guangzhou China. The Congress will be the largest meeting devoted exclusively to the research on vaccines and asociated technologies for disease prevention and treatment. There are 78 sessions and 5 workshops will be included in the congress. It will bring you the No. 1 largest speaker clusters and most influential event program in vaccine meeting history across the world. It aims at building a complete network for whole vaccine world.
The breathtaking and ambitious program is designed to cover almost all areas in frontier of Vaccinology, new technology innovations, vaccine R &D or discovery, regulatory, public health, safety and ethic issues, clinical practices, finance and business development, vaccine manufacturers and Procurement, equipment sellers and buyers, service and consulting providers, enabled technology and ready-to-go product licensing. Besides, BIT¡¯s World Vaccine Congress will also invite NGO health strategy planners to provide their alternative expert views on securing safe vaccines and educations for the public. It¡¯s believed that this annual congress of vaccine will provide enormous collaboration and insight information exchange opportunities. The first annual World Vaccine Congress will provide you a panorama update on today and next generation human and veterinary vaccines figured by
-Scheduling >600 oral presentations and panel discussions
-Showcasing 200 poster and 100 expositions
-Targeting 1500-2000 audiences from up to 80 countries
-Providing five training courses to serve educational purposes
-Arranging round table network for business and market development
-Organizing 2 Art and Culture Events
-Fostering friendship through a Warm Tour in the holly season to the ever-spring regions in southern China
As the top one information provider in Life Sciences in China, BIT Life Sciences hopes such an initiative can catalyze the generating One-For-All meeting place of Vaccines not only for Asia but also for the whole world. With its novel Videolization Technology to be launched later this year, BIT Life Sciences' World Vaccine Congress will guarantee to maximize the exposure for you to both professional society and public community no mater you are scientific innovators, decision makers, entrepreneurs and even laymen. The organizers wish BIT¡¯s Annual World Vaccine Congress can serve as the visualized "Science" and "Nature" Magazines for all parties interested in vaccine related issues.
The five day main conference along with 3 day tech tour to the most beautiful sightseeing place, Guilin, will provide you unforgettable meeting experiences in China.
Key speakers include:
Dr. John B Robbins
Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA
Dr. John D. Clemens Director General, International Vaccine Institute (IVI), Korea
Dr. Steven M. Ferguson
Director, Division of Technology Development and Transfer U.S. National Institutes of Health
Dr. Donald P. Francis
Former President & Co-founder VaxGen, Inc.
Executive Director and Co-founder, Global Solutions for Infectious Diseases, USA
Dr. Kai Chen
Vice President, Business Development IOMAI Corporation, USA
Dr. John W. Shiver
Vice President, Worldwide Basic Research Franchise Head, Vaccines Merck and Co., Inc. USA
Dr. Peter Khoury
Vice President, Global Marketing Baxter Bioscience-Vaccines, USA
Dr. Luc Aujame
Director, External R&D, Sanofi Pasteur, France
More than 70 distinguished Session Keynote Speakers and other 500+ high profile speakers from more than 80 countries are lining up.
FDA/CMS Summit
Host: Windhover Information
Date: Thursday, December 04, 2008 - Friday, December 05, 2008
Time: 8-5 pm
Location: The Westin Washington DC
Contact: Heej Ko
Phone: 203-838-4401 ext. 133
Fax: 203-838-3214
Email: hko@windhover.com
Website: http://www.windhover.com/fda-cms
Description: The Only Event where you can have face-to-face dialogue with top policy makers and executives on how to drive your pre- and post-regulatory approval and commercialization strategies
Key Benefits for Attending FDA/CMS Summit:
Hear the critical trends and changes that affect your regulatory strategy successful strategies for dealing with FDA and CMS
Walk away with practical, real life lessons from some of the most experienced pharmaceutical and biotechnology executives on how they handle regulatory obstacles
Get face-to-face access to the top regulatory thought leaders and policy makers
Benchmark your regulatory strategy against all the major pharmaceutical and biotech companies
Hear the Regulators' First-Hand Perspectives on:
User fees
Health care fraud prosecutions, especially in the new prescription drug benefit
Drug development and NDA approval strategies
Drug safety, risk management and post-market surveillance
Biogenerics/follow-on biologics
Personalized medicine
Pharma marketing and promotions regulation and enforcement
Marketing and promotion regulation and enforcement
Medicaid and Medicare reimbursement
Medicare Part D
Critical Path Initiative
Pricing Strategies
Holiday Breakfast Meeting
Host: BIOCOM
Date: Friday, December 05, 2008
Time: 7:00 a.m. - 9:00 a.m.
Location: San Diego Marriott La Jolla
Contact: Valerie Sanderson
Phone: 858-455-0300 ext.112
Fax:
Email: vsanderson@biocom.org
Website: http://www.biocom.org/event/DecemberBreakfast/
Description: You won't want to miss this fun breakfast as we close out 2008 with the very entertaining hypnotist, Tom Deluca. The perfect balance of entertainment and meaningful content, DeLuca's program will open the imagination to allow the creativity to emerge in an amazing way. Whether you want to be a volunteer to come up on stage or just watch from the sidelines, it will be a unique experience for us all.
The event will also include a presentation by a patient advocate and recognition of our 2008 BIOCOM committee members.
TERMIS-NA 2008 Conference & Expo
Host: TERMIS
Date: Sunday, December 07, 2008 - Wednesday, December 10, 2008
Time: 8:00am - 5:00pm
Location: San Diego, CA, USA
Contact: Anita Caufield, Forecast Technologies Group
Phone: 1-724-847-9921
Fax:
Email: gsaxton@conferencestrategists.com
Website: http://termis.org/na2008
Description: This prestigious event is where 800+ tissue engineering and regenerative medicine experts have gathered to listen and learn about the latest technological advances and new discoveries that are changing the paradigm of the industry, focusing on the advancements that drive these changes. TERMIS serves as an international forum to promote the informed discussion of challenges and therapeutic benefits of the application of tissue engineering and regenerative medicine technologies. This year's conference will provide a special focus on Organ Engineering, Stem Cells, and Immunology.
Antibody Engineering
Host: IBC Life Sciences
Date: Sunday, December 07, 2008 - Thursday, December 11, 2008
Location: Sheraton San Diego Hotel & Marina - San Diego, CA
Contact: IBC Customer Service
Phone: (800) 390-4078
Toll Free Phone: (800) 390-4078
Fax: (941) 365-0104
Email: reg@ibcusa.com
Website: www.IBCLifeSciences.com/Antibodyeng
Description: This year's 19th Antibody Engineering International Conference continues to promote interactions within this embryonic field and has become a hallmark of the field, by promoting personal interaction and presenting singular advances in antibody engineering, related binders, and resulting therapeutics, with a dramatic expansion of presentations selected by the Scientific Advisory Board.
BMD Summit
Host: IBC Life Sciences
Date: Monday, December 08, 2008 - Tuesday, December 09, 2008
Location: Washington Duke Inn & Golf Club . Durham, NC
Contact: IBC Customer Service
Phone: (800) 390-4078
Toll Free Phone: (800) 390-4078
Fax: (941) 365-0104
Email: reg@ibcusa.com
Website: www.IBCLifeSciences.com/BMD
Description: The BMD Summit is the one forum where you can gain in-depth knowledge in two complementary subject areas. Learn the newest uses for disposables, including their advantages and limitations, or learn how to apply the best principles for operational excellence to achieve lean manufacturing - or both!
New Horizons in Toxicity Prediction
Host: Lhasa Limited
Date: Monday, December 08, 2008 - Tuesday, December 09, 2008
Location: University of Cambridge, Dept of Chemistry, Lensfield Road, Cambridge, UK
Contact: Lhasa Limited
Phone: +44(0)113 394 6020
Fax: +44(0)113 394 6099
Email: marketing@lhasalimited.org
Website: http://www.lhasasymposium.com
Description: This exciting new event will explore various current approaches to toxicity prediction, covering and comparing the tools and methods available today, uses by regulators, industry and academia, plus a look at emerging areas and technologies.
Relevant to scientists working within the chemicals, pharmaceutical and personal care industries, academia, regulatory authorities and government agencies; this event offers an excellent opportunity for networking and hearing from prestigious keynote speakers.
Other: presentations from 16 high profile speakers, interactive panel discussion session, opportunities to network with leading professionals and a Symposium dinner hosted by prestigious Peterhouse, Cambridge's oldest collegiate building.
Genotoxic Impurities
Host: Lhasa Limited
Date: Monday, December 08, 2008 - Tuesday, December 09, 2008
Time: 8:00am
Location: The Inn at Penn, Philadelphia, PA
Contact: Jaclyn Grugett
Phone: 941-951-7885
Toll Free Phone: 1-888-670-8200
Fax: 941- 365-2507
Email: jgrugett@iirusa.com
Website: http://www.iirusa.com/gti/welcome.xml
Description: Comprehensive Answers to You Most Pressing GTI Challenges to Think Ahead:
* Regulatory Experiences: Hear current FDA and EU experiences to understand how to implement the EU Guidance
o Dr. Roland Froetschl, Genetic Toxicology. Federal Institute for Drugs and Medical Devices, BfArM, Germany
* Toxicology: Tools to assess Genotoxic Impurities and interpret the results
* Analytical Chemistry/CMC: Understand the methods and techniques to analyze and contain low level of impurities
* Process Chemistry/Quality Assurance: How to avoid and get rid of Genotoxic Impurities
Prepare Now! Take this Opportunity to:
* Compare the PhRMA, ICH, and EU papers and guidance
* Hear strategies for navigating the FDA GTI processes
* Understand toxicological perspective of risk assessment
* Explore the concept of Threshold of Toxicological Concern (TTC) to learn how regulators and industry are tackling this challenge
* Discover analytical approaches and chemical processes for understanding GTIs
* Discuss a risk-based approach for controlling GTIs
* Learn the structure determination and assessment of GTIs from forced degradation products
* Gain new prediction tools of degradation pathways and GTIs
Antibody Therapeutics
Host: IBC Life Sciences
Date: Tuesday, December 09, 2008 - Thursday, December 11, 2008
Location: Sheraton San Diego Hotel & Marina - San Diego, CA
Contact: IBC Customer Service
Phone: (800) 390-4078
Toll Free Phone: (800) 390-4078
Fax: (941) 365-0104
Email: reg@ibcusa.com
Website: www.IBCLifeSciences.com/Antibodyther
Description: Antibody Therapeutics provides a focused look at the preclinical and clinical development of antibody-based drug products. At this year's meeting, you will hear updates of preclinical and clinical stage programs, review the current state of the antibody therapeutics market and learn about trends in IP law that could impact your development candidates.
7th Annual LifeScience Alley - Conference & Expo
Host: LifeScience Alley
Date: Wednesday, December 10, 2008
Location: Minneapolis Convention Center. Minneapolis, MN
Contact: Jennifer Pinsch
Phone: 763-548-1303
Email: jennifer.pinsch@eventshows.com
Website: www.lifesciencealleyconference.org/index.html
Description: Be part of the largest gathering of life science leaders in the Upper Midwest. This annual conference features 4 keynote addresses and seminar tracks on Biologics & Pharmaceuticals, Medical Devices, Clinical & Regulatory Affairs, Research & Development, Emerging Companies, Innovation in Patient Care, and Food & Nutrition.
Bio meets Nano and IT
Host: BioForum Oulu
Date: Tuesday, December 09, 2008 - Thursday, December 11, 2008
Location: Hotel- restaurant Lasaretti, Oulu, Finland
Contact: Tuula Palmén /Bioforum Oulu
Phone:
Fax:
Email: tuula.palmen@bioforumoulu.org
Website: www.bmnit2008.com
Description: Bio Meets Nano and IT is a three-day conference that brings together companies, organizations and research groups with the purpose of increasing cross-technology interaction and business between life sciences, nanotechnology and information technology. The program consists of seminars, exhibitions, company visits and partnering events and it provides great networking and partnering possibilities internationally.
BioCenter Holiday Celebration & Trends In Financing Investor Panel
Host: San Jose BioCenter
Date: Thursday, December 11, 2008
Time: 3pm-6:30pm
Location: San Jose BioCenter
Contact: Aurelie Gaudin
Phone:
Fax:
Email: events@sjbiocenter.com
Website: http://www.sjbiocenter.com/event/ev_2008Q4-HolidayPartyAndTrendsInFinancingInves...
Description: The first key to get funding is to understand where the money is. Join experts from the Investment world at our annual "Trends in Financing Panel & Holiday Party" to understand the types of financings that are occurring in your industry today- including topics such as who is getting funding, current valuations and other terms, what investors are looking for, what criteria they use to evaluate and eventually fund your company, etc. - and what is new and what to expect for 2009.
Pharma Business Strategies for Biomarkers
Host: Windhover Information
Date: Thursday, December 11, 2008 - Friday, December 12, 2008
Time: 8-5 pm
Location: Intercontinental Mark Hopkins San Fran
Contact: Heej Ko
Phone: 203-838-4401 ext. 133
Fax: 203-838-3214
Email: hko@windhover.com
Website: http://www.windhover.com/conferences
Description: Are Biomarkers Required in the New Pharma Dealmaking World?
January 2009
CHI'S HIGH-CONTENT ANALYSIS 2009
Host: Cambridge Healthtech Institute
Date: Monday, January 05, 2009 - Friday, January 09, 2009
Time: All Day Event
Location: San Francisco, CA
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com
Description: Over the five years of organizing the HCA meeting, we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The Sixth Annual High-Content Analysis 2009 meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, and novel biological models for screening. We will also cover case studies and applications in compound screening, cytotoxicity evaluation, functional analysis, and more.
CHI'S HIGH-CONTENT ANALYSIS 2009
Host: Cambridge Healthtech Institute
Date: Tuesday, January 06, 2009 - Thursday, January 08, 2009
Location: San Francisco, CA
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: www.healthtech.com
CHI'S GLP BIOANALYSIS #3
Host: Cambridge Healthtech Institute
Date: Wednesday, January 07, 2009 - Thursday, January 08, 2009
Time: All Day Event
Location: San Francisco, CA
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com
Description: The course will provide detailed information and the current state-of-the-art knowledge on "must know" topics such as writing SOP's, the do's and don'ts for the GLP audit, and Quality Assurance.Ample time is allocated to each speaker in order to provide an interactive, in-depth tutorial with time for questions, detailed coverage of the subject and discussion of individual problems and situations. The audience will be strongly encouraged to interact, bring problems, discussion points or suggestions in order to brainstorm with the experts and share new information. You will be provided with printed handouts to follow along with the speakers and take notes.
CHI'S PEPTALK
Host: Cambridge Healthtech Institute
Date: Sunday, January 11, 2009 - Friday, January 16, 2009
Time: All Day Event
Location: San Diego, CA
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com
Description: . Second Annual Lyophilization 2009
. Inaugural Current Trends in Dosage Form Development & Biologics Formulation
. Inaugural Processes to Optimize Protein Purification & Recovery
. Inaugural Cell Culture: Fermentation & Media
. Second Annual Protein Production
. Fifth Annual Protein Therapeutics
. Inaugural Antibodies in Translation
. Inaugural Implementing the Next Generation of Antibodies
. Twelfth Annual Protein Expression
. Eighth Annual Protein Diagnostic Development
4th Annual Clinical Data Disclosure Summit
Host: ExL Pharma
Date: Monday, January 12, 2009 - Tuesday, January 13, 2009
Time: 8:00 AM - 5:30 PM
Location: Grand Hyatt Washington
Contact: Kristen Hunter
Phone: 212-400-6240
Toll Free Phone: NA
Fax: 888-221-6750
Email: info@exlpharma.com
Website: http://www.exlpharma.com/eventDetail.php?id=150
Description: The 2009 Clinical Data Disclosure Summit gathers industry executives who are all struggling to demystify the ambiguities of current regulations and implement internal processes for monitoring and maintaining compliance, to share their experiences, learn from one another and discuss the many questions that continue to go unanswered. As in past years the conference encourages maximum interaction with ample time for Q&A, roundtable discussions, multiple networking breaks and lunches as well as an informal presentation setting. So please bring your questions, your frustrations and your ideas and I look forward to seeing you in January.
Model Based Drug Development
Host: ExL Pharma
Date: Monday, January 12, 2009 - Tuesday, January 13, 2009
Time: 8:00 AM - 5:15 PM
Location: Loews Philadelphia Hotel
Contact: Sarah Ide
Phone: 212-400-6240
Toll Free Phone: NA
Fax: 888-221-6750
Email: info@exlpharma.com
Website: http://www.exlpharma.com/eventDetail.php?id=148
Description: Dear Colleague,
The current programmatic approach to drug development has not been keeping pace with advances in science and medicine. In an effort to modernize clinical research, the FDA has encouraged the pharmaceutical industry to shift from empirical to quantitative evaluation in the early stages of research. In response, many companies have worked to implement PK/PD modeling techniques into their development process, but have not yet realized the benefits of a more widespread application, incorporating in silico, in vitro, in vivo, and genomic modeling as well.
The adoption of model based drug development has been encouraged by both the FDA and PhRMA as a way to reduce the costs and time commitment of drug development by up to 50%. This two day conference brings together industry leaders to discuss new techniques to expand the use of modeling in bridging the gap between discovery and regulated research.
Patient Assistance Programs
Host: ExL Pharma
Date: Wednesday, January 14, 2009 - Thursday, January 15, 2009
Time: 8:00 AM - 5:30 PM
Location: Grand Hyatt Washington
Contact: Linsay Slater
Phone: 212-400-6240
Toll Free Phone: NA
Fax: 888-221-6750
Email: info@exlpharma.com
Website: http://www.exlpharma.com/eventDetail.php?id=146
Description: In today's healthcare environment, many patients are uninsured, underinsured, or are simply unable to afford the medications that they require. In order to combat the problem of inaccessible medications to low income individuals and families, a vast number of pharmaceutical companies offer patient assistance programs (PAPs) that provide medical products for free or at a discount to those who qualify. PAPs typically require a doctor's approval and proof of financial status. Corporate programs, funded and operated by the manufacturers, and foundation programs, which are run through independent, non-profit organizations funded by product manufacturers, are two of the major ways that patient assistant programs are designed and implemented.
Most manufacturers find that while there are many benefits of offering PAPs, this service can be costly to administer. In addition, the regulatory environment is complex, especially since the introduction of Medicare Part D. Companies must continually mind the rules as they fight to preserve a free-market healthcare system by providing medications to people who cannot afford to pay for them.
This conference will arm pharmaceutical companies with methods to maximize enrollment in their PAPs. Further, companies will learn how to run their programs more efficiently - cutting costs while maintaining quality. Through partnerships with nonprofit and government organizations, the industry can further position itself to most effectively provide vital medications to people in need.
Emerging Global Electronic Submission Standards
Host: ExL Pharma
Date: Thursday, January 22, 2009 - Friday, January 23, 2009
Time: 9:00 AM - 5:00 PM
Location: Gaylord National Resort and Convention Center
Contact: ExL Pharma
Phone: 212-400-6240
Toll Free Phone: NA
Fax: 888-221-6750
Email: info@exlpharma.com
Website: http://www.exlpharma.com/eventDetail.php?id=143
Description: Dear Colleague,
The Emerging Global Electronic Submission Standards conference will provide insight into the efficiencies of using eSubmissions as an alternative to paper. The eCTD, the electronic submission format accepted by the US, Japan, Canada, and most of Europe has not only greened the submission process but also has provided a preferable information sharing platform for drug development companies and health officials to communicate during the submission lifecycle.
This event will examine operational aspects such as the internal steps necessary for creating submission ready documents and content management as well as foward-looking issues such as eCTD alternatives and the progression of global standardization. Whether your company is beginning its eSubmission efforts or has already established a functional internal program, this event will provide a valuable resource for achieving product approval.
Repurposing Drugs
Host: IIR
Date: Thursday, January 22, 2009 - Friday, January 23, 2009
Time: 8:00am
Location: Red Rock Casino, Resort and Spa, Las Vegas, NV
Contact: Vania Bernardino
Phone: 941-951-7885
Toll Free Phone: 1-888-670-8200
Fax: 941- 365-2507
Email: vbernardino@iirusa.com
Website: http://www.iirusa.com/repurpose/welcome.xml
Description: This meeting offers detailed insights as industry thought leaders share strategies, technologies, and tools to reposition marketed or reformulated compounds.
* Fast forward your plans to repurpose drug and boost your pipeline
* Benefit from an exceptional speaking faculty who will provide solutions and strategies that you can implement to help reach maximum repurposing potential
* Explore the current and future potential of genetic and biomarker strategies in de novo drug development, and for the repurposing of existing drugs and molecular libraries
* Find out how novel (controlled release and targetable) drug delivery systems increase the marketability of drugs
* Learn how kinetic biomarkers can identify new indications of drugs and predict clinical response
* Overcome intellectual property challenges to patents and marketing exclusivity
* Uncover the current obstacles through case examples to discover the right solution for you
Nano Petroleum, Gas and Petro-Chemical Industries Conference: "Providing Nano-Powered Solutions"
Host: SabryCorp Ltd. for Science and Development.
Date: Saturday, January 24, 2009 - Tuesday, January 27, 2009
Location: Cairo, Egypt
Contact: Neveen Samy
Phone: +20 2 2414 6493
Fax: +20 2 2415 0992
Email: neveen.samy@sabrycorp.com
Website: www.npg.sabrycorp.com
Description: Nanotech has been recognized as the 21st century technology. The petroleum and gas industries are starting to realize the potential of nanotech research to revolutionize their work and desire to capitalize on nanotech's immense benefits. However, the current lack of communication between nanoresearch communities and the petrol and gas industries risks impeding progress. This conference provides a forum to bring research and industry together to advance the petrol and gas industries through nanotechnology.
Partnerships in Oncology Clinical Trials
Host: ExL Pharma
Date: Monday, January 26, 2009 - Tuesday, January 27, 2009
Time: 8:00 AM - 5:15 PM
Location: Loews Philadelphia Hotel
Contact: Sarah Ide
Phone: 212-400-6240
Toll Free Phone: NA
Fax: 888-221-6750
Email: info@exlpharma.com
Website: http://www.exlpharma.com/eventDetail.php?id=153
Description: Dear Colleague,
Oncology is the only therapeutic area to show consistent growth in recent decades. In spite of the enormous time and financial commitment of many pharmaceutical and biotechnology companies, the attrition rates for these drugs have remained well above the industry standard. The FDA, NIH, and NCI as well as multiple professional societies and consortia have worked to advance the techniques used in the development of these compounds, but this collaboration has not moved as quickly as hoped in introducing new drugs into this market. ExL Pharma's Partnering in Oncology Clinical Trials addresses best practices in maximizing partnerships with stakeholders in oncology research. Beyond improving the quality of the research, engaging partners in clinical research is an effective tool in cutting costs and timelines. Whether governmental or non-governmental organizations, every party in oncology clinical research approaches the research process in a different way, and with all involved parties represented at this event, new best practices can be shared and processes improved.
Phacilitate Cell & Gene Therapy Forum 2009
Host: Phacilitate
Date: Saturday, January 26, 2009 - Monday, January 28, 2009
Time: 09:00
Location: The Grand Hyatt Hotel, Washington, DC, United States
Contact: Becci Brolly
Phone: +44 (0)20 7839 6137
Fax: +44 (0)20 7839 6533
Email: team@phacilitate.co.uk
Website: http://www.phacilitate.co.uk/cgtherapy
Description: The Phacilitate Cell & Gene Therapy Forum provides an annual meeting place for senior level figures driving the transition of these technologies into safe, commercially viable products. The event gives technology companies, big pharma and biotech, the regulators and the investment community an unparalleled chance to exchange opinions and to network in exclusive, yet informal surroundings. The program features a stimulating blend of plenary sessions addressing key strategic challenges and breakout sessions promoting in-depth discussion of major business, regulatory and scientific issues. This format allows you to select between issues common to both cell and gene-based therapies and those specific to one or the other. The event runs concurrently with the Phacilitate Vaccine Forum Washington 2009.
Phacilitate Vaccine Forum Washington 2009
Host: Phacilitate
Date: Monday, January 26, 2009 - Wednesday, January 28, 2009
Time: 09:00
Location: The Grand Hyatt Hotel, Washington DC
Contact: Becci Brolly
Phone: +44 (0)20 7839 6137
Fax: +44 (0)20 7839 6533
Email: team@phacilitate.co.uk
Website: http://www.phacilitate.co.uk/wv
Description: Phacilitate's 7th annual North American Vaccine Forum will provide top-level executives from across the sector with an excellent opportunity to network and to exchange knowledge on the key strategic, regulatory, scientific and technological issues facing those developing novel prophylactic and therapeutic vaccines. Participants will be drawn from vaccine developers and manufacturers themselves, as well as the regulators and other key government agencies, NGOs and the investment community. The event runs concurrently with the Phacilitate Cell & Gene Therapy Forum 2009.
CHI'S TRANSLATIONAL CANCER MEDICINE
Host: Cambridge Healthtech Institute
Date: Monday, January 26, 2009 - Wednesday, January 28, 2009
Time: All Day Event
Location: San Diego, CA
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com
Description: The increasing technological advances in biomarker and target discovery, pre-clinical models, personalized medicine, and clinical trial design have the potential to expedite the translation of new discoveries to clinical practice. Oncology is the area that has perhaps benefited the most from these new technologies. The Translational Cancer Medicine meeting will identify the key opportunities to improve cancer diagnosis and treatment, as well as provide case studies of successful (and not so successful) drug development. The pre-conference workshop will provide a comprehensive survey of novel cancer biomarkers. Translational Cancer Medicine is co-located with the Biomarker Assay Development meeting.
CHI'S BIOMARKER ASSAY DEVELOPMENT
Host: Cambridge Healthtech Institute
Date: Monday, January 26, 2009 - Wednesday, January 28, 2009
Time: All Day Event
Location: San Diego, CA
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com
Description: The increasing importance of biomarkers in the drug discovery process calls for a comprehensive biomarker strategy that must include assay development and validation. CHI's Inaugural Biomarker Assay Development meeting addresses "fit-for-purpose" method development, spanning pre-clinical and clinical drug development, as well as diagnostics. The meeting will provide an overview of novel assay platforms for genomic and proteomic analysis, as well as multiplexed assays, flow cytometry, and more. It will also discuss the pros and cons of developing the assay in-house vs. adopting off-the-shelf solutions/kits vs. outsourcing. And finally, since the meeting is co-located with the Translational Cancer Medicine meeting, it will also focus on biomarker assays in oncology.
7th Annual Partnering with Central Labs, ECG & Imaging Labs
Host: IIR
Date: Monday, January 26, 2009 - Wednesday, January 28, 2009
Location: Red Rock Casino Resort & Spa
Contact:
Phone: 888-670-8200
Fax:
Email: register@iirusa.com
Website: www.partneringwithlabs.com
Description: IIR's 7th Annual Partnering with Central labs, ECG, & Imaging labs event lets Pharmaceutical sponsors compare core labs to ensure you make the best choice to reduce costs of your trials.
With an outstanding speaking faculty with access to leading central labs, ECG core labs, imaging core labs, specialty labs and couriers and other small, medium and large pharmaceutical sponsors this event will add critical business value now.
Prepare your company for more streamlined and compliant drug development with solutions to handle day-to-day outsourcing, procurement, operations and data management. Visit www.partneringwithlabs.com for more information. Mention Code XP1405BIO and join us on January 26th in Las Vegas.
Cool Chain Europe 2009
Host: IQPC
Date: Wednesday, January 28, 2009 - Thursday, January 29, 2009
Time: 0900
Location: Airport Hotel and Conference Centre, Brussels, Belgium
Contact: Suzannah Povey
Phone: +44 (0)207 368 9713
Fax: +44 (0)207 368 9301
Email: enquire@iqpc.co.uk
Website: http://www.coolchaineurope.com/uk/coolchaineurope/ediary
Description: Strap line: An end to failed shipments
New International Speakers:
. Motivational Keynote Speaker
. World or European Customs Officials
. Cross Industry Case Studies from Food and Fine Arts
. Sophisticated Supply Chain Case Studies
New Programme Topics:
. International Cold Chains - Gaining Regulatory Feedback from UK, US,
Europe, China, South America and India
. Target China - A Seminar on how to Handle Customs Challenges, Evolving
Regulatory Expectations, Identify Suitable Freight Forwarders, Brokers and
Transport Partners
. Transport of Biopharmaceutical Products - Exploring Cost-Effective
Options for Qualified Shipping of Bulk Products
. Downstream Distribution and the Last Miles of the Cold Chain - How can
we gain Greater Control of Valuable, Needed Medicines in the Last Leg of
our Supply Chains?
February 2009
Drug Discovery for Neurodegneration
Host: Alzheimer's Drug Discovery Foundation
Date: Monday, February 02, 2009 - Tuesday, February 03, 2009
Location: Park Hyatt Washington DC
Contact: Conference Secretariat
Phone: 773-784-8134
Fax:
Email: meetings@worldeventsforum.com
Website: www.alzdiscovery.org
Description: The purpose of the conference is to advance drug discovery for neurodegenerative disease by educating academic scientists on the processes of translating basic research into novel therapies. The conference will give participants knowledge and relevant resources about this field of scientific investigation; and address the associated barriers and challenges. Speakers and chairs will present lectures and case studies on Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis and other 'orphan' neurological diseases. Ample time for questions and networking is also integrated into the program.
Comparability Challenges: Regulatory and Scientific Issues in the Assessment of Biopharmaceuticals
Host: Drug Information Association
Date: February 3-4, 2009
Location: Sheraton National Hotel, Arlington, VA, USA
Contact: Carrie Dunn
Phone: 215-442-6181
Fax: 215.293.5987
Email: Carrie.Dunn@diahome.org
Website: http://www.diahome.org
Description: Participate in an Industry and FDA Conference to Address the Data Necessary to Provide Assurance of Comparability for Manufacturing Changes. During the lifetime of all products, there is a need to make changes in production methods, the impact of which must be evaluated for quality purposes as well as for submission to regulatory authorities. This is especially important for biotechnology-derived products whose characteristics are closely related to the manufacturing process. The FDA requires information to establish comparability between current products and products following manufacturing changes. Depending on the change, in vitro comparisons, animal data, clinical data, or some combination of these areas, may be necessary. Featured topics will include: Characterization of changes in cell lines, process scale, formulation/presentation and the comparative data necessary to support these changes; Discussion of in vitro biochemical, preclinical (pharmacokinetics, pharmacodynamics, toxicology, immunogenicity), or clinical data needed for some changes and value of these data; and Case studies and the data requested by regulatory authorities.
BioPartnering North America
Host:
Date: Sunday, February 08, 2009 - Tuesday, February 10, 2009
Location: Vancouver, British Columbia, Canada
Contact: Technology Vision Group
Phone: 1.831.464.4230
Fax: 1.831.464.4240
Email: contact@techvision.com
Website: http://www.techvision.com/bpn/
Description: The 7th Annual BioPartnering North America (BPN) conference is North America's most innovative life science partnering conference. The conference offers a variety of partnering opportunities including company presentations, partnering software, interactive sessions and workshops with industry leaders. Come to BPN and experience the best networking opportunities with life science business development executives.
Other: Technology Vision Group LLC, 5200 Soquel Avenue, Suite 202, Santa Cruz, CA 95062 USA. Tel.: +1.831.464.4230. Fax: +1.831.464.4240
Clinical Trials Congress
Host: Institute for International Research
Date: Monday, February 09, 2009 - Wednesday, February 11, 2009
Location: Philadelphia, PA
Contact: Allison Rigels
Phone: 646-895-7327
Toll Free Phone: 888.670.8200
Fax:
Email: arigels@iirusa.com
Website: www.clinicalevent.com
ASAP 2009 GLOBAL ALLIANCE SUMMIT
Host: Cambridge Healthtech Institute
Date: Monday, February 09, 2009 - Thursday, February 12, 2009
Time: All Day Event
Location: Ft. Lauderdale, FL
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com
CALAsia- Bridging the Pacific
Host: BIOCOM
Date: Saturday, February 23, 2009 - Monday, February 25, 2009
Location: San Diego Marriott Hotel & Marina
Contact: Valerie Sanderson
Phone: 858-455-0300 ext.112
Fax:
Email: vsanderson@biocom.org
Website: http://www.biocom.org/event/calasia/
Description: CALAsia is the only international forum to connect key life science decision-makers from California and Asia Pacific together to identify, explore, and further trans-Pacific business endeavors.
Representatives of the international life science community, including established and emerging companies, pharmaceutical companies, investors, academic and research institutions and delegations representing several Asia Pacific countries will meet face-to-face in February of 2009, when BIOCOM hosts this global conference.
CHI'S MOLECULAR MEDICINE TRI-CONFERENCE
Host: Cambridge Healthtech Institute
Date: Tuesday, February 24, 2009 - Friday, February 27, 2009
Time: All Day Event
Location: San Francisco, CA
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com
Description: The Fifteenth International Molecular Medicine Tri-Conference delivered the hottest areas of biotechnology brought together in one location. Molecular Diagnostics, Medicinal Chemistry, Stem Cells and Translational Medicine were the buzz at this year's event. The presenters delivered pragmatic and solution-driven insights that captivated the audience and the exhibit hall delivered more technologies than ever before. Attendance hit historic levels reaching 2800 delegates for first time. The continued growth of the event is a strong indicator that the confluence of biology, chemistry and business is being realized.
March 2009
Bio-Pharma: Mastering the Business of Science
Host: Babson Executive Education
Date: March 3 - 5, 2009 (Module 1)
Date: April 14 - 15, 2009 (Module 2)
Time: N/A
Location: Babson Executive Conference Center - Wellesley, MA
Contact: Dierdre Murphy - Open Enrollment Programs - Babson Executive Education
Phone: 781 239-4340
Toll Free Phone: 800 882-EXEC (3932)
Fax: 781 239-5266
Email: dmurphy@babson.edu
Website: www.babson.edu/bee/bio
Description: Program is designed exclusively for mid- to senior-level bio-pharma scientists and professionals, From competitive and financial strategies to industry and social trends, the program teaches you to identify and manage the drivers of business and personal success. Specifically, you will: Learn to take a broader, more strategic role in your organization by strengthening your understanding of the strategy, finance, marketing, and leadership issues specific to the life sciences industry. Strengthen your coaching capabilities. Develop project, portfolio, and risk management strategies. Anticipate future trends in your industry and assess their likely impact on your company's success-and your own professional development. Network with other life sciences peers and industry practitioners
Other: Program is offered in a two module format (to minimize consecutive days out of the office)
March 3 - 5, 2009 (Module 1)
April 14 - 15, 2009 (Module 2)
CHI'S DRUG DEVELOPMENT LATIN AMERICA
Host: Cambridge Healthtech Institute
Date: Monday, March 09, 2009 - Tuesday, March 10, 2009
Time: All Day Event
Location: Miami, FL
Contact: CHI Representative
Phone: 781 972 5400
Fax: 781 972 5425
Email: chi@healthtech.com
Website: http://www.healthtech.com
Description: The globalization of R&D into emerging regions continues. Growing R&D spending in these regions has been driven by many factors including the attractiveness of commercial markets there, more favorable economics including lower relative costs for greater speed, access to highly skilled professional labor and a large pool of patients, particularly treatment-naïve ones.
Polymorphism & Crystallisation 2009
Host: PharmaIQ
Date: Wednesday, March 11, 2009 - Thursday, March 12, 2009
Location: Thistle Marble Arch, London, UK
Contact: Enquiries
Phone: +44 (0)20 7368 9300
Fax: +44 (0)20 7368 9301
Email: enquire@iqpc.co.uk
Website: http://www.iqpc.com/uk/poly
Description: Europe's leading forum for crystal form development is returning to London in March 2009. Polymorphism and Crystallisation 2009 will give you critical updates on new analytical technologies, groundbreaking case studies and cutting edge scale-up strategies, enabling you to benchmark your organisations development processes.
A key focus for companies working in the industry is to not only to reduce the impurities and improve the properties of drugs for further development, but also to look at the correct analytical and characterisation techniques. Ensuring effective patent protection and patent term extension, whilst gaining increased market share in this current financial climate.
Confirmed Speakers Include:
. Professor Roger Davey, Molecular Engineering, University of Manchester
. Dr Michael Millan, Director of Pharma, Avantium
. Dr Surya Devarakonda, Associate Director, API Research and Development, Dr Reddys
. Dr Fiona Thorley, Research Director, Aptuit
. Dr Ingvar Ymén, Analytical Chemist, AstraZeneca
. Professor Leslie Leiserowitz, The Patricia Elman Bildner Professor of Solid State Chemistry, Weizmann Institute
. Dr Rolf Hilfiker, Head of Department, Solid State Development, Vice President, Solvias
. Professor William Jones, Materials Chemistry Group, University of Cambridge
Discovery 2009
Host: Marcus Evans
Date: Monday, March 23, 2009 - Wednesday, March 25, 2009
Location: Le Méridien Beach Plaza, Monte-Carlo, Monaco
Contact: Maria Tembriotou
Phone: 357 22849333
Fax:
Email: requests@marcusevanscy.com
Website: http://www.discovery-summit.com/
Description: The Discovery Summit 2009 will highlight the industry's current challenges and opportunities on a global level through international keynote presentations and case studies delivered by the most esteemed thought leaders in the industry. The Discovery Summit 2009 presents a unique opportunity to examine the challenges and advances in drug discovery.
|
Printer Friendly
